{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:10:15Z","timestamp":1768677015041,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Science","award":["KBBE-211757"],"award-info":[{"award-number":["KBBE-211757"]}]},{"name":"EU Network of Excellence EPIZONE"},{"name":"EU Coordination and Support Action ARBO-ZOONET"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.043","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T13:29:39Z","timestamp":1304861379000},"page":"4469-4475","source":"Crossref","is-referenced-by-count":60,"title":["A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR\u2212\/\u2212 mice upon lethal virus challenge"],"prefix":"10.1016","volume":"29","author":[{"given":"Hani","family":"Boshra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.04.043_bib0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J Am Vet Med Assoc"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.043_bib0010","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid1307.061487","article-title":"Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003","volume":"13","author":"Faye","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"January\u2013May (1)","key":"10.1016\/j.vaccine.2011.04.043_bib0015","first-page":"31","article-title":"Recognizing Rift Valley fever","volume":"42","author":"Davies","year":"2006","journal-title":"Vet Ital"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2011.04.043_bib0020","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.04.043_bib0025","first-page":"34","article-title":"Enzootic hepatitis of Rift Valley fever","volume":"34","author":"Daubney","year":"1931","journal-title":"J Pathol Bacteriol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.04.043_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0264-410X(86)90007-1","article-title":"Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials","volume":"4","author":"Meadors","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.04.043_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"Kamal","year":"2009","journal-title":"Virol J"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.04.043_bib0040","first-page":"19506","article-title":"Rift Valley fever--a threat for Europe?","volume":"15","author":"Chevalier","year":"2010","journal-title":"Euro Surveill"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.04.043_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2011.04.043_bib0050","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.04.043_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"Mandell","year":"2010","journal-title":"Virology"},{"issue":"November (49\u201350)","key":"10.1016\/j.vaccine.2011.04.043_bib0060","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"issue":"June (29)","key":"10.1016\/j.vaccine.2011.04.043_bib0065","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.04.043_bib0070","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.04.043_bib0075","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.043_bib0080","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pntd.0000725","article-title":"Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus","volume":"4","author":"Bhardwaj","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2011.04.043_bib0085","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(\u2212\/\u2212) mice induced by different DNA vaccination regimens","volume":"28","author":"Lorenzo","year":"2010","journal-title":"Vaccine"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.04.043_bib0090","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1128\/JVI.00752-06","article-title":"Crimean-Congo hemorrhagic fever virus genomics and global diversity","volume":"80","author":"Deyde","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.04.043_bib0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol J"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.04.043_bib0100","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1128\/JVI.72.6.5174-5181.1998","article-title":"DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination","volume":"72","author":"Rodriguez","year":"1998","journal-title":"J Virol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.043_bib0105","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.159.12.6037","article-title":"Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes","volume":"159","author":"Wu","year":"1997","journal-title":"J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.04.043_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0300-9475.2004.01442.x","article-title":"vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine","volume":"60","author":"Wang","year":"2004","journal-title":"Scand J Immunol"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.04.043_bib0115","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.vaccine.2007.12.057","article-title":"A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets","volume":"26","author":"Hou","year":"2008","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.04.043_bib0120","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1128\/JVI.71.11.8497-8503.1997","article-title":"DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction","volume":"71","author":"Rodriguez","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.043_bib0125","first-page":"35","article-title":"Immune and protective abilities of ubiquitinated and non-ubiquitinated pseudorabies virus glycoproteins","volume":"51","author":"Gravier","year":"2007","journal-title":"Acta Virol"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2011.04.043_bib0130","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.vaccine.2006.02.028","article-title":"DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses","volume":"24","author":"Borrego","year":"2006","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.043_bib0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"September (25)","key":"10.1016\/j.vaccine.2011.04.043_bib0140","doi-asserted-by":"crossref","first-page":"16269","DOI":"10.1016\/S0021-9258(18)55288-1","article-title":"Targeting of lysosomal integral membrane protein LIMP II. The tyrosine-lacking carboxyl cytoplasmic tail of LIMP II is sufficient for direct targeting to lysosomes","volume":"266","author":"Vega","year":"1991","journal-title":"J Biol Chem"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2011.04.043_bib0145","doi-asserted-by":"crossref","first-page":"10421","DOI":"10.1128\/JVI.75.21.10421-10430.2001","article-title":"CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting","volume":"75","author":"Rodriguez","year":"2001","journal-title":"J Virol"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2011.04.043_bib0150","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1128\/JVI.01210-06","article-title":"DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge","volume":"80","author":"Fernandez-Borges","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.04.043_bib0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.04.043_bib0160","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.170.2.989","article-title":"Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep","volume":"170","author":"Manoj","year":"2003","journal-title":"J Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.04.043_bib0165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/CVI.00080-06","article-title":"Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks","volume":"13","author":"Gares","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"January (5247)","key":"10.1016\/j.vaccine.2011.04.043_bib0170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.04.043_bib0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1570162053506937","article-title":"C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences","volume":"3","author":"Bower","year":"2005","journal-title":"Curr HIV Res"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.043_bib0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00262-009-0727-2","article-title":"Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth","volume":"59","author":"Liang","year":"2010","journal-title":"Cancer Immunol Immunother"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2011.04.043_bib0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-2427(01)00369-5","article-title":"Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization","volume":"83","author":"Suradhat","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.04.043_bib0190","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J Virol"},{"issue":"December","key":"10.1016\/j.vaccine.2011.04.043_bib0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1358.008","article-title":"CD154 gene therapy for human B-cell malignancies","volume":"1062","author":"Messmer","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.04.043_bib0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/intimm\/dxh205","article-title":"C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria","volume":"17","author":"Bergmann-Leitner","year":"2005","journal-title":"Int Immunol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.04.043_bib0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/mabs.2.3.11676","article-title":"Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization","volume":"2","author":"Martin-Folgar","year":"2010","journal-title":"MAbs"},{"issue":"November\u2013December (16\u201317)","key":"10.1016\/j.vaccine.2011.04.043_bib0210","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0161-5890(97)00147-8","article-title":"Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope","volume":"34","author":"Dalum","year":"1997","journal-title":"Mol Immunol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.04.043_bib0215","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.188.4.681","article-title":"Protection against respiratory syncytial virus infection by DNA immunization","volume":"188","author":"Li","year":"1998","journal-title":"J Exp Med"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2011.04.043_bib0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1006\/viro.1997.8507","article-title":"Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes","volume":"231","author":"Zeller","year":"1997","journal-title":"Virology"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2011.04.043_bib0225","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0042-6822(91)90999-R","article-title":"Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein","volume":"183","author":"Sumner","year":"1991","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2011.04.043_bib0230","doi-asserted-by":"crossref","first-page":"e2517","DOI":"10.1371\/journal.pone.0002517","article-title":"Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens","volume":"3","author":"Laddy","year":"2008","journal-title":"PloS ONE"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2011.04.043_bib0235","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11005883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T15:56:41Z","timestamp":1712419001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11005883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":47,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11005883"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}